A Bayesian approach to sequential analysis in post‐licensure vaccine safety surveillance
暂无分享,去创建一个
[1] Sander Greenland,et al. Invited Commentary: The Need for Cognitive Science in Methodology , 2017, American journal of epidemiology.
[2] Ruihua Yin,et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. , 2011, Vaccine.
[3] I R Silva,et al. Continuous versus group sequential analysis for post‐market drug and vaccine safety surveillance , 2015, Biometrics.
[4] M. Kulldorff,et al. A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance , 2011 .
[5] J. Nelson,et al. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013–2014 and 2014–2015 seasons , 2016, Pharmacoepidemiology and drug safety.
[6] D J Spiegelhalter,et al. The what, why and how of Bayesian clinical trials monitoring. , 1994, Statistics in medicine.
[7] Michael Goldstein,et al. Subjective Bayesian Analysis: Principles and Practice , 2006 .
[8] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[9] Ivair Ramos Silva,et al. Type I Error Probability Spending for Post-Market Drug and Vaccine Safety Surveillance With Poisson Data , 2017, Methodology and Computing in Applied Probability.
[10] J Jack Lee,et al. Bayesian clinical trials in action , 2012, Statistics in medicine.
[11] D L DeMets,et al. Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.
[12] W Katherine Yih,et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. , 2009, Vaccine.
[13] Thomas R Fanshawe,et al. A Bayesian approach to sequential meta‐analysis , 2016, Statistics in medicine.
[14] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[15] W. Satariano,et al. A comparison of two worlds: How does Bayes hold up to the status quo for the analysis of clinical trials? , 2011, Contemporary clinical trials.
[16] Rongxia Li,et al. Continuous sequential boundaries for vaccine safety surveillance , 2014, Statistics in medicine.
[17] Yuanyuan Tang,et al. A Bayesian Meta-analysis Method for Estimating Risk Difference of Rare Events , 2018, Journal of biopharmaceutical statistics.
[18] J. Berger. The case for objective Bayesian analysis , 2006 .
[19] D J Spiegelhalter,et al. Comparison of Bayesian with group sequential methods for monitoring clinical trials. , 1989, Controlled clinical trials.
[20] Daniel L Gillen,et al. Bayesian evaluation of group sequential clinical trial designs , 2007, Statistics in medicine.
[21] T. Lai,et al. Sequential generalized likelihood ratio tests for vaccine safety evaluation , 2010, Statistics in medicine.
[22] W Katherine Yih,et al. Real-Time Surveillance to Assess Risk of Intussusception and Other Adverse Events After Pentavalent, Bovine-Derived Rotavirus Vaccine , 2010, The Pediatric infectious disease journal.
[23] Jennifer C. Nelson,et al. Statistical performance of group sequential methods for observational post-licensure medical product safety surveillance: A simulation study , 2012 .
[24] M. Kulldorff,et al. Absence of associations between influenza vaccines and increased risks of seizures, Guillain–Barré syndrome, encephalitis, or anaphylaxis in the 2012–2013 season , 2014, Pharmacoepidemiology and drug safety.
[25] W Katherine Yih,et al. Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures , 2010, Pediatrics.
[26] S. Greene,et al. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. , 2012, Vaccine.
[27] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .